13.02
price up icon13.22%   1.52
pre-market  Vorhandelsmarkt:  13.28   0.26   +2.00%
loading
Schlusskurs vom Vortag:
$11.50
Offen:
$11.58
24-Stunden-Volumen:
149.47K
Relative Volume:
2.59
Marktkapitalisierung:
$77.62M
Einnahmen:
$100.44M
Nettoeinkommen (Verlust:
$-133.16M
KGV:
-0.5054
EPS:
-25.76
Netto-Cashflow:
$-94.85M
1W Leistung:
+40.45%
1M Leistung:
+63.98%
6M Leistung:
+88.97%
1J Leistung:
+28.53%
1-Tages-Spanne:
Value
$11.58
$13.21
1-Wochen-Bereich:
Value
$8.53
$13.21
52-Wochen-Spanne:
Value
$5.005
$18.70

Atara Biotherapeutics Inc Stock (ATRA) Company Profile

Name
Firmenname
Atara Biotherapeutics Inc
Name
Telefon
805-623-4211
Name
Adresse
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA
Name
Mitarbeiter
89
Name
Twitter
@Atarabio
Name
Nächster Verdiensttermin
2024-11-18
Name
Neueste SEC-Einreichungen
Name
ATRA's Discussions on Twitter

Vergleichen Sie ATRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ATRA
Atara Biotherapeutics Inc
13.02 55.26M 100.44M -133.16M -94.85M -25.76
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Atara Biotherapeutics Inc Stock (ATRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-11-09 Herabstufung Evercore ISI Outperform → In-line
2023-11-09 Herabstufung H.C. Wainwright Buy → Neutral
2023-11-09 Herabstufung Mizuho Buy → Neutral
2022-07-20 Herabstufung Citigroup Neutral → Sell
2022-07-13 Herabstufung JP Morgan Overweight → Neutral
2022-07-13 Herabstufung Stifel Buy → Hold
2022-05-10 Herabstufung Citigroup Buy → Neutral
2021-05-13 Hochstufung JP Morgan Neutral → Overweight
2020-12-09 Herabstufung Citigroup Buy → Neutral
2020-12-08 Bestätigt H.C. Wainwright Buy
2020-11-10 Bestätigt H.C. Wainwright Buy
2020-06-30 Eingeleitet Evercore ISI Outperform
2020-06-15 Eingeleitet H.C. Wainwright Buy
2020-04-23 Hochstufung Citigroup Neutral → Buy
2019-11-08 Herabstufung JP Morgan Overweight → Neutral
2019-09-27 Herabstufung Goldman Neutral → Sell
2019-09-16 Herabstufung Jefferies Buy → Hold
2019-06-04 Hochstufung Citigroup Sell → Neutral
2019-05-30 Eingeleitet ROTH Capital Buy
2019-05-23 Eingeleitet Stifel Buy
2019-01-23 Eingeleitet Mizuho Buy
2018-04-10 Eingeleitet JP Morgan Overweight
2018-03-16 Eingeleitet Guggenheim Neutral
2018-03-05 Bestätigt Jefferies Buy
2018-02-28 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2018-02-15 Herabstufung Citigroup Neutral → Sell
2018-01-03 Hochstufung Citigroup Sell → Neutral
2017-10-06 Fortgesetzt Goldman Neutral
Alle ansehen

Atara Biotherapeutics Inc Aktie (ATRA) Neueste Nachrichten

pulisher
04:18 AM

Innovation Ltd Panacea Buys 19,335 Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Stock - Defense World

04:18 AM
pulisher
01:48 AM

Is Atara Biotherapeutics Inc. a good long term investmentConsistent triple-digit returns - jammulinksnews.com

01:48 AM
pulisher
Jul 22, 2025

What analysts say about Atara Biotherapeutics Inc. stockFree Stock Market Query - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Atara stock gains after insider purchase (ATRA:NASDAQ) - Seeking Alpha

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Atara Biotherapeutics Inc. stock priceSuperior stock selection - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Atara Biotherapeutics Inc. Stock Analysis and ForecastHigh-profit trading signals - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

(ATRA) Trading Advice - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 15, 2025

How Atara Biotherapeutics Inc. stock performs during market volatilityDaily Breakout Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Atara Biotherapeutics Inc. stock attracts strong analyst attentionFree Discussion Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Atara Biotherapeutics Inc. stock price move sharplyFree Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Major FDA Development: Pierre Fabre Assumes Control of Atara's EBV Cell Therapy Program After BLA Resubmission - Stock Titan

Jul 15, 2025
pulisher
Jul 14, 2025

Atara Biotherapeutics Resubmits BLA for Tab-cel to FDA - TipRanks

Jul 14, 2025
pulisher
Jul 14, 2025

Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel®) | ATRA Stock News - GuruFocus

Jul 14, 2025
pulisher
Jul 14, 2025

Atara Biotherapeutics provides regulatory and business updates on tabelecleucel (tab-cel) - MarketScreener

Jul 14, 2025
pulisher
Jul 14, 2025

Atara resubmits tabelecleucel BLA to FDA for EBV-positive PTLD By Investing.com - Investing.com Canada

Jul 14, 2025
pulisher
Jul 14, 2025

Atara resubmits tabelecleucel BLA to FDA for EBV-positive PTLD - Investing.com

Jul 14, 2025
pulisher
Jul 14, 2025

Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel - Business Wire

Jul 14, 2025
pulisher
Jul 10, 2025

(ATRA) Technical Data - news.stocktradersdaily.com

Jul 10, 2025
pulisher
Jul 08, 2025

We Might See A Profit From Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Soon - simplywall.st

Jul 08, 2025
pulisher
Jun 30, 2025

Atara Biotherapeutics, Inc.(NasdaqGS: ATRA) added to Russell Microcap Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025
pulisher
Jun 11, 2025

Atara Biotherapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 11, 2025
pulisher
Jun 06, 2025

Long Term Trading Analysis for (ATRA) - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Purchases New Position in Atara Biotherapeutics, Inc. (NASDAQ:ATRA) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Short Interest Update - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Bank of America Corp DE Acquires 1,543 Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) - Defense World

Jun 02, 2025
pulisher
May 29, 2025

Redmile Group, LLC's Strategic Acquisition in Atara Biotherapeutics Inc - GuruFocus

May 29, 2025
pulisher
May 28, 2025

Here's Why You Should Consider Buying Atara Biotherapeutics Stock - Barchart.com

May 28, 2025
pulisher
May 28, 2025

Biotech Pioneer Pascal Touchon Joins CDR-Life Board: Former Atara CEO to Drive T Cell Platform Innovation - Stock Titan

May 28, 2025
pulisher
May 22, 2025

Atara Biotherapeutics (NASDAQ:ATRA) & Turnstone Biologics (NASDAQ:TSBX) Financial Analysis - Defense World

May 22, 2025
pulisher
May 20, 2025

Top Executives at Atara Biotherapeutics Make Significant Stock Sales! - TipRanks

May 20, 2025
pulisher
May 20, 2025

Atara Biotherapeutics Executives Sell Shares for Tax Obligations - TradingView

May 20, 2025
pulisher
May 20, 2025

Citadel Advisors LLC Has $3.56 Million Position in Atara Biotherapeutics, Inc. (NASDAQ:ATRA) - Defense World

May 20, 2025
pulisher
May 19, 2025

FDA Delivers Blow to ImmunityBio - Los Angeles Business Journal

May 19, 2025

Finanzdaten der Atara Biotherapeutics Inc-Aktie (ATRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):